Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
MYCB1-BDL
- Development stage
- Unknown
- Lead developer
- MYCB1
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral, Sublingual
01
Overview
MYCB1-BDL is a full-spectrum medical cannabis oil extract developed and manufactured by MYCB1. It is derived from the standardized Bedrolite (BDL) cannabis strain, which is a cannabidiol (CBD)-rich and low-tetrahydrocannabinol (THC) strain sourced from Bedrocan. Formulated as an oily resin solution (such as MYCB1-BDL 1:100, containing 1 mg/mL THC and 100 mg/mL CBD), it is distributed via pharmacies in Germany and other European markets. MYCB1-BDL is prescribed for the management of conditions such as difficult-to-treat epilepsy, chronic pain, and spasticity, and is integrated with MYCB1's ALETTA digital platform to collect real-world evidence on patient outcomes.
- Brand names
- MYCB1-BDLMYCB-1-BDLMYCB 1-BDL
- Other names
- MYCB1-BDL 1:100Ölige Cannabisharzöl-Lösung MYCB1 BDL 1:100
02
Targets
CNR1 (Cannabinoid receptor 1)
Beyond the preview
Go deeper on MYCB1-BDL.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MYCB1-BDL.